Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

KAIST develops semiconductor neuron that harnesses noise to selectively process signals

August 16, 2026
Continue Reading
kaist-develops-semiconductor-neuron-that-harnesses-noise-to-selectively-process-signals
Posted inBiotechnology

Imagining natural and extra robotic thumbs together strengthens kinesthetic sensorimotor networks

August 15, 2026
Continue Reading
imagining-natural-and-extra-robotic-thumbs-together-strengthens-kinesthetic-sensorimotor-networks
Posted inBiotechnology

PARP1 Drives Neuropathic Pain Through GPX4-Dependent Ferroptosis in Injured Mice’s Sensory Neurons

August 15, 2026
Continue Reading
parp1-drives-neuropathic-pain-through-gpx4-dependent-ferroptosis-in-injured-mice’s-sensory-neurons
Posted inBiotechnology

Strubbelig–NHL3 Receptor Complex Helps Arabidopsis Respond to Cellulose Deficiency

August 15, 2026
Continue Reading
strubbelig–nhl3-receptor-complex-helps-arabidopsis-respond-to-cellulose-deficiency
Posted inBiotechnology

Bombyx mori Satellitome Analysis Reveals Evolutionary Stability, Dispersed Chromosomal Organization, Transposon Origins

August 15, 2026
Continue Reading
bombyx-mori-satellitome-analysis-reveals-evolutionary-stability,-dispersed-chromosomal-organization,-transposon-origins
Posted inBiotechnology

Genome-wide skin pQTL map reveals genetic regulators and mechanisms underlying skin disorders

August 15, 2026
Continue Reading
genome-wide-skin-pqtl-map-reveals-genetic-regulators-and-mechanisms-underlying-skin-disorders
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

chutes-&-ladders—fda’s-principal-deputy-to-depart-agency
Posted inBiotechnology

Chutes & Ladders—FDA’s principal deputy to depart agency

December 19, 2024
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please…
Read More
omeros-antibody-improves-overall-survival-by-68%-in-rare-condition,-new-analysis-finds
Posted inBiotechnology

Omeros antibody improves overall survival by 68% in rare condition, new analysis finds

December 19, 2024
Omeros is putting up its monoclonal antibody up for FDA approval—again. This time, the resubmission will be based on a…
Read More
merck’s-hiv-combo-treatment-meets-the-bar-for-viral-suppression-in-pair-of-phase-3-studies
Posted inBiotechnology

Merck’s HIV combo treatment meets the bar for viral suppression in pair of phase 3 studies

December 19, 2024
After hitting the mark in a phase 2 of its investigational islatravir paired with Gilead’s lenacapivir, Merck & Co.'s islatravir…
Read More
vc-firm-pens-$608m-biobucks-deal-to-redirect-ngm’s-mash-drug-to-rare-disease
Posted inBiotechnology

VC firm pens $608M biobucks deal to redirect NGM’s MASH drug to rare disease

December 19, 2024
KdT Ventures has signed off on a $608 million biobucks deal for NGM Biopharmaceuticals’ phase 2-ready metabolic-dysfunction associated steatohepatitis (MASH)…
Read More
scinai-immunotherapeutics-establishes-us.-cdmo-subsidiary
Posted inGenetics

Scinai Immunotherapeutics Establishes U.S. CDMO Subsidiary

December 19, 2024
Scinai Immunotherapeutics, which focuses on developing inflammation and immunology biological products and providing CDMO services through its Scinai Bioservices business…
Read More
regeneron-anticoagulant-bests-enoxaparin,-matches-eliquis-in-phase-2-trial
Posted inBiotechnology

Regeneron anticoagulant bests enoxaparin, matches Eliquis in phase 2 trial

December 19, 2024
A pair of Regeneron’s monoclonal antibodies have held their own against a commonly used anticoagulant in a phase 2 trial,…
Read More
vertex’s-pain-trial-hits-endpoint-but-sinks-stock-as-placebo-comparison-spooks-investors
Posted inBiotechnology

Vertex’s pain trial hits endpoint but sinks stock as placebo comparison spooks investors

December 19, 2024
Vertex has reported a phase 2 win that still dented confidence in its pain prospect suzetrigine. The trial linked the near-approval…
Read More
electrocore-to-buy-neurometrix-and-its-quell-fibromyalgia-wearable-stimulator
Posted inMedical Technology

ElectroCore to buy NeuroMetrix and its Quell fibromyalgia wearable stimulator

December 19, 2024
Nerve stimulation company electroCore has signed an agreement to acquire NeuroMetrix and its Quell wearable device aimed at fibromyalgia and…
Read More
uncovering-craniopharyngioma’s-growth-mechanism-may-identify-new-therapy
Posted inGenetics

Uncovering Craniopharyngioma’s Growth Mechanism May Identify New Therapy

December 19, 2024
Craniopharyngioma, a benign yet highly invasive tumor occurring along the hypothalamus-pituitary axis, presents a unique clinical challenge. Although nonmalignant, its…
Read More
former-seagen-ceo’s-biotech-raises-$140m-series-a-to-ready-pd1/vegfr2-antibody-for-clinic
Posted inBiotechnology

Former Seagen CEO’s biotech raises $140M series A to ready PD1/VEGFR2 antibody for clinic

December 19, 2024
Two months after former Seagen CEO David Epstein unveiled his new project, the biotech has secured "over" $140 million in…
Read More

Posts pagination

Previous page 1 … 2,182 2,183 2,184 2,185 2,186 … 2,196 Next page
You May Have Missed
Posted inMedical Technology

Medtronic veteran Bill Shields crosses over to become CEO at valve disease startup

Posted inMedical Technology

Samsung hearing aid features for its ear buds garner FDA clearance

Posted inMedical Technology

Abbott teams with Google Health on AI-powered health insights app

Posted inMedical Technology

Labcorp nabs FDA green light for BRAF melanoma diagnostic

Privacy Policy    Terms

Scroll to Top